STEM Related Analyst Ratings
-
Ascendiant Capital Starts StemCells (STEM) at Buy
-
Maxim Group Starts StemCells (STEM) at Buy
-
Roth Capital Downgrades StemCells (STEM) to Neutral
-
StemCells (STEM) Will Get 'Significant Portion' of Requested $20M from California -Roth Capital
-
Roth Capital Starts StemCells (STEM) at Buy
-
Chardan Capital Starts StemCells (STEM) at Buy, $1.45 Price Target
-
Dawson James Initiates Coverage on StemCells (STEM) with a Speculative Buy
-
Merriman Curhan Starts STEM at Neutral
Back to STEM Stock Lookup
